Executive Health Program Cost: Annual Benchmark

A comprehensive executive health program at Mayo Clinic runs $5,000 to $11,000 per visit — and nearly none of it is covered by your employer-sponsored health plan. That single data point defines the financial reality most program marketing glosses over: executive health programs are largely a cash-pay category, sitting outside insurance reimbursement and carrying a cost structure that demands its own line in a household budget.

Key Cost Figures at a Glance

Sources: TCTMD (August 2025); PartnerMD published pricing; Fountain Life published pricing; Cleveland Clinic executive health program documentation; IRS Publication 969 (2025).

What the Market Actually Charges: A Tier-by-Tier Breakdown

The executive health program market splits into three distinct cost tiers, and conflating them is the most common mistake households make when budgeting. The services, diagnostic depth, and ongoing-care commitments differ substantially across tiers — not just the price.

Tier 1: Academic Medical Centers ($5,000–$25,000, event-based)

Mayo Clinic’s executive health program costs between $5,000 and $11,000 per engagement, according to a 2025 clinical pricing analysis published by TCTMD. Cleveland Clinic’s premier package ranges from $5,000 to $25,000 depending on the diagnostic tests included, with a standard executive physical at the lower end and multi-day cardiovascular and cancer screening packages at the top. These are generally episodic — a single comprehensive visit, annually or biannually — rather than ongoing subscription arrangements. Johns Hopkins prices its program at $4,500 to $10,000 per executive, with scheduling centered on its Baltimore campus.

One structural feature of academic medical center programs that matters for budgeting: they bundle diagnostic results across specialties in a single visit. An executive who would otherwise spend two weeks coordinating cardiology, gastroenterology, and dermatology appointments gets consolidated outcomes in one day. That time compression has real value. It doesn’t make the price tag disappear, but it reframes what the cost covers relative to a fragmented specialist schedule.

Tier 2: Regional and Concierge-Adjacent Programs ($2,700–$6,000)

PartnerMD, one of the more transparent pricers in the industry, publishes its concierge medicine executive physical at $2,700 to $4,000 depending on exam scope. Emory Healthcare’s program falls in the $3,000 to $5,000 range based on age, gender, and testing scope. Vanderbilt University Medical Center offers a cardiac-only package at $3,500. These programs typically deliver a rigorous comprehensive physical with advanced bloodwork and cardiovascular screening, but without the full multi-specialist depth of the top-tier academic programs.

For households comparing MDVIP vs One Medical pricing alongside executive programs, it’s worth keeping the service models separate. MDVIP and similar concierge retainer models provide ongoing primary care access — typically $2,000 to $5,000 per year — while executive health programs deliver a concentrated diagnostic event. The two are not substitutes. Some households carry both.

Tier 3: Longevity and Precision Health Platforms ($20,000+, subscription)

Fountain Life’s APEX membership runs $19,500 to $21,500 annually, covering whole-body MRI, coronary CT angiography, comprehensive biomarker panels, genetic testing, and concierge physician access on an ongoing basis. The CORE membership starts at $2,995 for quarterly blood tests and physician consultations without imaging. This tier operates on a different logic than the academic medical center model: it’s a continuous monitoring subscription rather than an annual event, designed around early disease detection through repeated high-resolution imaging and biomarker trending over time.

Sources: TCTMD clinical analysis (August 2025); PartnerMD published pricing (2024–2025); Fountain Life published pricing (2025–2026); Fountain Life competitor analysis via GRN Labs (January 2026).

The Insurance Gap: What Your Plan Won’t Touch

Cleveland Clinic’s own executive health documentation states that “many insurance carriers only cover a very small portion of Executive Health services.” That’s the institutional version of a polite admission. In practice, the structure of what insurance actually reimburses leaves most of the bill on the individual or employer.

Standard employer-sponsored plans cover preventive care as defined under the Affordable Care Act — routine bloodwork, basic physical, age-appropriate cancer screenings. What executive programs add — advanced cardiac imaging, whole-body MRI, coronary CT angiography, genetic panels, extended specialist consultations — falls outside standard preventive care definitions and typically generates no insurance reimbursement. The out-of-pocket cost at $200k income for these add-ons runs to the full billed amount.

The average worker contribution toward family employer health insurance premiums was $6,296 in 2024, per KFF’s 2024 Employer Health Benefits Survey — and that covers the base plan. Executive program costs land on top of that figure. The out-of-pocket maximum for an employer-sponsored plan may limit exposure on in-network medical claims, but executive health programs operating outside the insurance network bypass that protection entirely.

Some individual diagnostic components — specific bloodwork panels, EKG — may qualify for partial reimbursement as covered preventive services, depending on the insurer and plan. Providers confirm this varies significantly. The conservative budget assumption is full cash-pay for the program cost, with incidental reimbursement for individual line items as a potential offset rather than a reliable credit.

HSA Interaction: The Partial Relief Valve

A health savings account (HSA) offers one legitimate path to pre-tax funding for executive health program costs — with critical constraints. The IRS confirms that qualified medical expenses paid from an HSA are tax-free, and executive physical components that meet the definition of medical diagnostic procedures under IRS rules are generally eligible. The program packaging fee itself, when it bundles non-medical wellness services, may not be fully HSA-eligible. The practical guidance from tax practitioners: request an itemized receipt and submit eligible diagnostic components for HSA reimbursement, not the bundled program fee.

For 2025 and 2026, the HSA family contribution limit is $8,550, per IRS Publication 969 (2025) — unchanged between the two years. Individual (self-only) coverage allows $4,300. Those 55 and older can contribute an additional $1,000 catch-up contribution. The HSA must pair with a qualifying high-deductible health plan (HDHP), which carries its own cost implications when compared against HSA-eligible plan vs. PPO net annual cost trade-offs.

Modeled at 7% investment growth on maxed family contributions, an unfunded HSA balance compounding over 10 years reaches approximately $117,700 before distributions — meaningful against a $5,000–$10,000 annual executive health program cost. The HSA maximization savings math over a decade makes the HDHP trade-off worth running carefully. But the HSA alone doesn’t close the gap on Tier 3 programs running $20,000 per year.

Starting January 1, 2026, direct primary care (DPC) membership fees qualify as HSA-eligible expenses under expanded IRS rules, capped at $150 per month for individuals and $300 per month for families. That change matters for households combining direct primary care vs. insurance with an executive health program — the DPC retainer can now be HSA-funded, freeing cash for the executive program fee.

Sources: IRS Publication 969 (2025); GRF CPAs & Advisors HSA analysis; IRS/ALPA 2026 benefit limit guidance (January 2026).

Finluxy Healthcare Spend Index: Benchmarking the Real Cost

The Finluxy Healthcare Spend Index measures household annual out-of-pocket healthcare spend — excluding premiums — as a percentage of gross income. The KFF benchmark for $150k+ households sits at 1.2%–2.5% of gross income. Executive health program costs, added on top of standard out-of-pocket spending, can push households above that range depending on program tier and income level.

Base OOP figure: Peterson-KFF Health System Tracker, family of four, 2024 data (February 2026 publication). Executive program costs: provider pricing as cited above. Income scenarios are illustrative. Finluxy Healthcare Spend Index = OOP spend ÷ gross income × 100.

The index calculation makes the decision-forcing question concrete: a household earning $200,000 that selects a mid-tier executive program is running healthcare spend at 3.78% of gross income — nearly double the top of the KFF benchmark range. That’s not inherently wrong, but it’s a different budget category than a “premium health benefit.” It’s a deliberate choice to spend 2+ percentage points of gross income above benchmark on a service that has no insurance backstop. The annual healthcare spend for $150k+ families context matters here: most high-earning households are already above the national OOP average, and executive programs add a discrete, predictable layer on top.

The Overlooked Variable: Diagnostic Yield vs. Annual Spend

Most coverage of executive health programs focuses on what the programs include — the test menus, the physician access, the same-day turnaround. What the cost data actually reveals, and what almost no analysis addresses directly, is that the value proposition hinges entirely on diagnostic yield at a specific age and risk profile. A 42-year-old with no family history of cardiovascular disease running a $10,000 cardiac imaging battery is buying a very different actuarial bet than a 55-year-old with elevated Lp(a) and a first-degree relative with early heart disease.

A 2025 clinical analysis published by TCTMD found that cardiologists questioned the evidence base for the advanced cardiovascular screening bundled into most executive programs, noting that the programs leverage institutional reputation rather than clinical guidelines for the specific diagnostic tests offered. That critique applies unevenly — it’s most relevant to healthy, low-risk individuals in their 40s and least relevant to older executives with elevated risk factors where early detection genuinely changes management. The $5,000–$25,000 spend range doesn’t adjust for this. The institutions charge the same regardless of whether the diagnostic density is warranted by the individual’s risk profile.

For $150k+ households, the practical implication is to approach premium healthcare cost decisions the same way they approach investment due diligence: expected value, not brand association. A $3,500 Vanderbilt cardiac package for a 50-year-old executive with borderline hypertension may generate more actionable clinical information than a $15,000 comprehensive program where most of the additional testing lands in low-yield categories.

Employer Reimbursement and Tax Treatment

Many executive health program participants don’t pay personally — their employer covers the cost as a corporate benefit, most commonly through a health reimbursement arrangement (HRA) or direct employer payment. The tax treatment matters: employer-paid executive physicals are generally taxable compensation to the executive unless structured through a qualified medical plan, per IRS rules on discriminatory benefits under Code Section 105(h). Employers offering executive physicals only to highly compensated employees face potential inclusion of the benefit value in taxable wages. This is a frequently overlooked compliance issue, not a cost-reduction opportunity.

For self-employed $150k+ earners, the picture is cleaner. The diagnostic components of an executive physical may qualify as a deductible medical expense on Schedule A, subject to the 7.5% AGI floor — which at $200,000 income means expenses above $15,000 become deductible. At a $6,000 executive physical cost added to a household’s other OOP spending, Schedule A deductibility rarely triggers unless the household has significant additional qualifying medical expenses. The HSA route, when available, remains the more reliable pre-tax vehicle, covering eligible diagnostic components regardless of the AGI floor. The mental health coverage gaps at this income tier add another layer: many executive programs include mental health assessments that also fail to generate insurance reimbursement.

Building the Annual TCO: What a $150k+ Household Actually Spends

Stack the full picture using the cluster’s total cost of ownership framework. A household earning $200,000 with family employer coverage, an HDHP/HSA plan, and a mid-tier executive health program carries the following annual healthcare TCO:

KFF 2024 Employer Health Benefits Survey (October 2024); Peterson-KFF Health System Tracker (February 2026); PartnerMD pricing (2024–2025). HDHP/SO worker contribution for family: KFF 2024 data reports average family HDHP/SO premium at $24,196; applying average worker share of approximately 25.3% yields $6,124.

That TCO sits at 7.3%–8.1% of gross income before the HSA tax benefit. Maximize the HSA family contribution at $8,550 — contributed pre-tax in the 32% marginal bracket — and the after-tax TCO drops by roughly $2,736. Adjusted for the HSA tax benefit, the effective cost lands closer to 6.0%–6.8% of gross income. Still well above the KFF benchmark for OOP-only spend, but that benchmark excludes premiums and the executive program layer that households at this income level deliberately carry. The ACA subsidy cliff at lower income bands is entirely irrelevant here; $150k+ households price their healthcare from first principles.